We thank Dr. David Wasserman of LI-COR Biosciences for use of their equipment and guidance in the in vivo study. We also thank U24 CA92871, R01 CA134675 and K25 CA148901 for financial support. SPECT=single photon emission computed tomography.
Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen†
Version of Record online: 22 AUG 2011
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 50, Issue 39, pages 9167–9170, September 19, 2011
How to Cite
Banerjee, S. R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Foss, C. A., Green, G., Fox, J. J., Lupold, S. E., Mease, R. C. and Pomper, M. G. (2011), Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen. Angew. Chem. Int. Ed., 50: 9167–9170. doi: 10.1002/anie.201102872
- Issue online: 15 SEP 2011
- Version of Record online: 22 AUG 2011
- Manuscript Revised: 24 JUN 2011
- Manuscript Received: 26 APR 2011
- U24. Grant Number: CA92871
- R01. Grant Number: CA134675
- K25. Grant Number: CA148901
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.